Literature DB >> 828774

The economic cost of illness revisited.

B S Cooper, D P Rice.   

Abstract

In and out of government, determining the cost of illness is a major concern. The allocation of health care resources and the evaluation of current research and program efforts depend in large measure on such information. This article updates the 1963 benchmark study of the cost of illness. For the 16 major diagnostic categories of illnesses, the cost is presented in terms of the direct costs for prevention,detection, and treatment; the morbidity losses due to disability; and the mortality losses resulting from premature death. The method of calculating the cost of any illness is described, and data necessary for the calculation are provided. In 1972, the estimated total cost of illness was $188 billion: $75 billion for direct costs, $42 billion for morbidity, and $71 billion for mortality. Diseases of the circulatory system were the most costly, representing about one-fifth of all costs of illness.

Mesh:

Substances:

Year:  1976        PMID: 828774

Source DB:  PubMed          Journal:  Soc Secur Bull        ISSN: 0037-7910


  45 in total

Review 1.  Medical costs of smoking in the United States: estimates, their validity, and their implications.

Authors:  K E Warner; T A Hodgson; C E Carroll
Journal:  Tob Control       Date:  1999       Impact factor: 7.552

2.  Costs of diabetes. A methodological analysis of the literature.

Authors:  E Pagano; M Brunetti; F Tediosi; L Garattini
Journal:  Pharmacoeconomics       Date:  1999-06       Impact factor: 4.981

3.  Prostate cancer: 12. The economic burden.

Authors:  S A Grover; H Zowall; L Coupal; M D Krahn
Journal:  CMAJ       Date:  1999-03-09       Impact factor: 8.262

4.  Cost of disease and illness in the United States in the year 2000.

Authors: 
Journal:  Public Health Rep       Date:  1978 Sep-Oct       Impact factor: 2.792

5.  The Australian Guidelines for subsidisation of pharmaceuticals: the road to cost-effective drug prescribing?

Authors:  M Johannesson
Journal:  Pharmacoeconomics       Date:  1992-11       Impact factor: 4.981

Review 6.  The economic costs of asthma: a review and conceptual model.

Authors:  K B Weiss; S D Sullivan
Journal:  Pharmacoeconomics       Date:  1993-07       Impact factor: 4.981

7.  Economic evaluation of drug therapy: a review of the contingent valuation method.

Authors:  M Johannesson; P O Johansson; B Jönsson
Journal:  Pharmacoeconomics       Date:  1992-05       Impact factor: 4.981

Review 8.  Cost-of-illness studies : a review of current methods.

Authors:  Ebere Akobundu; Jing Ju; Lisa Blatt; C Daniel Mullins
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

9.  Estimating the full cost of workplace injuries.

Authors:  M T French
Journal:  Am J Public Health       Date:  1990-09       Impact factor: 9.308

Review 10.  Defining and measuring the costs of the HIV epidemic to business firms.

Authors:  P G Farnham
Journal:  Public Health Rep       Date:  1994 May-Jun       Impact factor: 2.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.